| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | EDWARDS LIFESCIENCES CORP | 83,500 | 8,327,000 | 0.62% | ||
| 52 | HOLOGIC INC | 230,000 | 7,958,000 | 0.59% | ||
| 53 | SERES THERAPEUTICS INC | 262,000 | 7,611,000 | 0.56% | ||
| 54 | JUNO THERAPEUTICS INC COM | 197,001 | 7,573,000 | 0.56% | ||
| 55 | ENVISION HEALTHCARE HLDGS INC | 291,000 | 7,383,000 | 0.55% | ||
| 56 | INTRA-CELLULAR THERAPIES INC | 190,000 | 7,376,000 | 0.55% | ||
| 57 | VERTEX PHARMACEUTICALS INC | 85,500 | 7,355,000 | 0.54% | ||
| 58 | OPHTHOTECH CORP | 142,500 | 7,272,000 | 0.54% | ||
| 59 | AMERICAN RENAL ASSOCIATES HO | 250,000 | 7,243,000 | 0.54% | ||
| 60 | CORSICANTO LTD | 7,000,000 | 7,214,000 | 0.53% | PRN | |
| 61 | ULTRAGENYX PHARMACEUTICAL INC COM | 141,500 | 6,921,000 | 0.51% | ||
| 62 | COHERUS BIOSCIENCES INC COM | 400,000 | 6,756,000 | 0.50% | ||
| 63 | BEIGENE LTD | 225,000 | 6,705,000 | 0.50% | ||
| 64 | RTI SURGICAL HOLDINGS INC COM | 1,860,000 | 6,677,000 | 0.49% | ||
| 65 | CORVUS PHARMACEUTICALS INC COM | 450,000 | 6,417,000 | 0.48% | ||
| 66 | INVITAE CORP | 858,380 | 6,343,000 | 0.47% | ||
| 67 | FIVE PRIME THERAPEUTICS INC | 153,000 | 6,327,000 | 0.47% | ||
| 68 | ATHENA HEALTH INC. | 45,750 | 6,314,000 | 0.47% | ||
| 69 | ADAPTIMMUNE THERAPEUTICS PLC | 765,001 | 6,235,000 | 0.46% | ||
| 70 | NOVAVAX INC COM | 852,500 | 6,198,000 | 0.46% | ||
| 71 | CARDIOME PHARMA CORP | 1,200,000 | 6,144,000 | 0.45% | ||
| 72 | EPIZYME INC COM | 597,500 | 6,118,000 | 0.45% | ||
| 73 | MACROGENICS INC | 225,000 | 6,073,000 | 0.45% | ||
| 74 | HILL ROM HLDGS INC | 120,000 | 6,054,000 | 0.45% | ||
| 75 | REGENERON PHARMACEUTICALS | 17,000 | 5,937,000 | 0.44% | ||
| 76 | EGALET CORP | 7,800,000 | 5,923,000 | 0.44% | PRN | |
| 77 | PARATEK PHARMACEUTICALS INC | 418,500 | 5,821,000 | 0.43% | ||
| 78 | NOVADAQ TECHNOLOGIES INC | 555,000 | 5,461,000 | 0.40% | ||
| 79 | AVEXIS INC COM | 142,758 | 5,428,000 | 0.40% | ||
| 80 | COMPUGEN LTD | 820,000 | 5,314,000 | 0.39% | ||
| 81 | CHINA CORD BLOOD CORP | 880,000 | 5,060,000 | 0.37% | ||
| 82 | PROTEOSTASIS THERAPEUTICS IN COM | 415,000 | 5,034,000 | 0.37% | ||
| 83 | INSMED INC | 497,500 | 4,905,000 | 0.36% | ||
| 84 | INSYS THERAPEUTICS INC NEW COM NEW | 365,500 | 4,730,000 | 0.35% | ||
| 85 | ADURO BIOTECH INC | 415,000 | 4,694,000 | 0.35% | ||
| 86 | ALDER BIOPHARMACEUTICALS INC | 180,500 | 4,507,000 | 0.33% | ||
| 87 | TANDEM DIABETES CARE INC COM | 595,000 | 4,486,000 | 0.33% | ||
| 88 | Intersect ENT Inc | 340,000 | 4,396,000 | 0.33% | ||
| 89 | ALLERGAN PLC | 5,000 | 4,164,000 | 0.31% | ||
| 90 | PORTOLA PHARMACEUTICALS INC | 175,000 | 4,130,000 | 0.31% | ||
| 91 | KITE PHARMA INCORPORATED | 80,000 | 4,000,000 | 0.30% | ||
| 92 | Ascendis Pharma | 300,000 | 3,981,000 | 0.29% | ||
| 93 | RIGEL PHARMACEUTICAL INC | 1,750,000 | 3,903,000 | 0.29% | ||
| 94 | Otonomy Inc | 240,000 | 3,811,000 | 0.28% | ||
| 95 | AMICUS THERAPEUTICS INC COM | 680,000 | 3,713,000 | 0.27% | ||
| 96 | FIBROGEN INC | 225,000 | 3,692,000 | 0.27% | ||
| 97 | AURIS MED HLDG AG | 850,000 | 3,562,000 | 0.26% | ||
| 98 | MEDICINES CO SR GLBL CV NT 22 | 3,000,000 | 3,549,000 | 0.26% | PRN | |
| 99 | INNOVIVA INC COM | 336,900 | 3,548,000 | 0.26% | ||
| 100 | ENDOCHOICE HLDGS INC | 710,000 | 3,479,000 | 0.26% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-16-003863, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
